Triglyceride reference ranges
Pro Research Analysisby 
Searched over 200M research papers
Triglyceride Reference Ranges: Clinical and Population Insights
Standard Triglyceride Reference Ranges and Clinical Guidelines
Clinical guidelines commonly focus on triglyceride levels between 2.3 and 5.6 mmol/L (200–499 mg/dL) as the range of concern for cardiovascular risk and therapeutic intervention. However, research shows that cardiovascular risk increases across the full biological range of triglyceride levels, not just within this constrained range. Individuals with mild-to-moderate hypertriglyceridemia (within the 2.3–5.6 mmol/L range) may not have as high a cardiovascular risk as those with higher or lower triglyceride levels outside this range, suggesting that broader reference intervals may be clinically relevant for risk assessment and future trials Nordestgaard2025Nordestgaard2024.
Reference Ranges in Healthy Populations
Studies in healthy adults have established reference intervals for triglyceride levels, both fasting and non-fasting. For example, in a healthy middle-aged and elderly population in Beijing, the 4-hour postprandial (non-fasting) triglyceride reference range was found to be 0.82 to 3.02 mmol/L, with median values around 1.6 mmol/L. There were no significant differences in postprandial triglyceride levels between age or sex groups in this population .
In a large US population, fasting serum triglyceride levels below 150 mg/dL (1.7 mmol/L) are considered within the normal range. However, even within this range, higher triglyceride levels (above 95 mg/dL or 1.08 mmol/L) were associated with increased diabetes mortality, indicating that risk may begin to rise even before reaching the upper limit of the traditional normal range .
Triglyceride Subclasses and Demographic Differences
Advanced measurement techniques, such as nuclear magnetic resonance (NMR) and high-performance liquid chromatography, have allowed for the subclassification of triglycerides into various lipoprotein fractions. Reference intervals for these sub-fractions show that concentrations tend to increase with age, body mass index (BMI), and in individuals with cardiovascular disease or diabetes. Men generally have higher levels of certain triglyceride-rich subclasses (e.g., large VLDL), while women, especially postmenopausal, may have higher levels in other subclasses. These differences highlight the importance of considering sex, age, and menopausal status when interpreting triglyceride levels Furusyo2013Joshi2020.
Triglyceride/HDL Ratio Reference Values
The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio is another marker used to assess cardiometabolic risk. Reference values for this ratio have been established as 2.6 for men and 1.7 for women, with these cut-offs reliably identifying individuals at risk for hypertension, diabetes, obesity, metabolic syndrome, and insulin resistance across different ethnicities .
Triglyceride Levels and Health Outcomes
Lower triglyceride levels are associated with better endothelial function, and individuals with extremely low triglyceride levels (<50 mg/dL or 0.56 mmol/L) have the best vascular health markers. Conversely, higher triglyceride levels, even within the normal range, are linked to increased risk of diabetes mortality and, in some studies, all-cause mortality. The relationship between triglyceride levels and mortality risk can be non-linear, with both very low and very high levels associated with increased risk in certain populations, such as those with cardiovascular disease or obesity Wang2024Takaeko2021Li2023+1 MORE.
Conclusion
Triglyceride reference ranges vary depending on fasting status, age, sex, and measurement method. While traditional clinical guidelines focus on levels above 2.3 mmol/L (200 mg/dL), evidence suggests that cardiovascular and metabolic risk can increase across the full spectrum of triglyceride levels, including within the normal range. Reference intervals for triglyceride sub-fractions and ratios like TG/HDL-C provide additional tools for risk assessment. Clinicians should consider individual patient characteristics and emerging evidence when interpreting triglyceride levels and making management decisions.
Sources and full results
Most relevant research papers on this topic